Article
Drug Repurposing of β-blocker Propranolol in Osteosarcoma: Preclinical Antitumor Efficacy Alone or in Combination with Chemotherapy.
2020-07-22
Abstract excerpt
<title>Abstract</title> <p><bold>Background:</bold> Osteosarcoma is still associated with poor response to therapy and alarmingly elevated mortality rates, especially in developing countries, highlighting the urgent need of novel therapeutic strategies. Given that β-adrenergic receptor (β-AR) signaling regulates many cellular processes involved in the initiation and progression of cancer, multiple efforts have be...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- d830b3ec-1cec-5be2-99f1-4622547f7514
- DOI
- 10.21203/rs.3.rs-44912/v1
